Turning Point Therapeutics Inc (TPTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | TPTX | CRNX | NAMS | ||
| Company | Turning Point Therapeutics Inc | Crinetics Pharmaceuticals Inc | Newamsterdam Pharma Company N.V. | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 75.99 | 35.83 | 31.65 | ||
| High | 76.01 | 37.29 | 33.23 | ||
| Low | 75.98 | 35.83 | 31.61 | ||
| Latest | 76.01 | 37.23 | 32.99 | ||
| Change | +0.52 | +0.66 | +0.18 | ||
| % Change | +0.69% | +1.80% | +0.55% | ||
| Volume | 2,843,300 | 1,247,900 | 725,300 | ||
| 20-Day Average Volume | 962,475 | 1,263,925 | 839,855 | ||
| Previous Close | 75.49 | 36.57 | 32.81 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 75.11 | 36.36 | 30.52 | ||
| 20-Day Raw Stochastic | 100.00% | 60.69% | 91.11% | ||
| 20-Day Relative Strength | 74.20 | 43.39 | 53.36 | ||
| Weighted Alpha | -18.70 | +8.57 | +83.34 | ||
| Today's Opinion | 96% Buy | 56% Sell | 8% Sell | ||
| Previous Opinion | 96% Buy | 56% Sell | 8% Sell | ||
| Last Month's Opinion | 88% Buy | 8% Sell | 8% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +1.29% since 08/09/22 | +2.53% since 03/26/26 | +5.57% since 03/26/26 | ||
| Low | 74.86 on 08/10/22 | 33.10 on 03/30/26 | 29.08 on 03/30/26 | ||
| High | 76.01 on 08/16/22 | 37.51 on 04/01/26 | 33.42 on 04/01/26 | ||
| 1-Month | |||||
| %Chg | +1.82% since 07/15/22 | -8.48% since 03/02/26 | +0.49% since 03/02/26 | ||
| Low | 74.57 on 07/21/22 | 33.10 on 03/30/26 | 28.53 on 03/13/26 | ||
| High | 76.01 on 08/16/22 | 40.90 on 03/03/26 | 33.42 on 04/01/26 | ||
| 3-Month | |||||
| %Chg | +134.02% since 05/16/22 | -20.33% since 01/02/26 | -6.28% since 01/02/26 | ||
| Low | 30.85 on 05/25/22 | 33.10 on 03/30/26 | 28.53 on 03/13/26 | ||
| High | 76.01 on 08/16/22 | 57.99 on 01/05/26 | 37.76 on 02/18/26 | ||
| 6-Month | |||||
| %Chg | +124.48% since 02/16/22 | -10.31% since 10/02/25 | +7.46% since 10/02/25 | ||
| Low | 23.77 on 03/15/22 | 33.10 on 03/30/26 | 28.53 on 03/13/26 | ||
| High | 76.01 on 08/16/22 | 57.99 on 01/05/26 | 42.00 on 11/26/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 3,806,125 | 3,898,167 | 3,793,025 | ||
| Shares Outstanding, K | 50,074 | 104,705 | 114,975 | ||
| Annual Sales | 30,830,000 | 7,700,000 | 22,500,000 | ||
| Annual Net Income | -236,550,000 | -465,320,000 | -203,820,000 | ||
| Last Quarter Sales | 120,000 | 6,160,000 | 30,000 | ||
| Last Quarter Net Income | -123,090,000 | -122,820,000 | -74,920,000 | ||
| 60-Month Beta | -0.18 | 0.30 | 0.13 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -2.48 on 08/08/22 | -1.29 on 02/26/26 | -0.63 on 02/18/26 | ||
| Latest Earnings Date | 11/08/22 | 05/14/26 | 05/14/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||